How to buy Harpoon Therapeutics stock - 05 March

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Harpoon Therapeutics stock

Own Harpoon Therapeutics stock in just a few minutes.


Fact checked

Harpoon Therapeutics, Inc is a biotechnology business based in the US. Harpoon Therapeutics shares (HARP) are listed on the NASDAQ and all prices are listed in US Dollars. Harpoon Therapeutics employs 77 staff and has a trailing 12-month revenue of around USD$12.2 million.

How to buy shares in Harpoon Therapeutics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Harpoon Therapeutics. Find the stock by name or ticker symbol: HARP. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Harpoon Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Harpoon Therapeutics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Harpoon Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Harpoon Therapeutics share price

Use our graph to track the performance of HARP stocks over time.

Harpoon Therapeutics shares at a glance

Information last updated 2021-03-03.
52-week rangeUSD$10.27 - USD$25.235
50-day moving average USD$20.2532
200-day moving average USD$16.6821
Wall St. target priceUSD$31.89
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-4.049

Buy Harpoon Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
Get two free stock valued between $2.50 and $250
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Harpoon Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Harpoon Therapeutics financials

Revenue TTM USD$12.2 million
Gross profit TTM USD$-35,815,000
Return on assets TTM -20.97%
Return on equity TTM -62.89%
Profit margin 0%
Book value $2.404
Market capitalisation USD$629.3 million

TTM: trailing 12 months

Shorting Harpoon Therapeutics shares

There are currently 678,029 Harpoon Therapeutics shares held short by investors – that's known as Harpoon Therapeutics's "short interest". This figure is 5.8% down from 719,686 last month.

There are a few different ways that this level of interest in shorting Harpoon Therapeutics shares can be evaluated.

Harpoon Therapeutics's "short interest ratio" (SIR)

Harpoon Therapeutics's "short interest ratio" (SIR) is the quantity of Harpoon Therapeutics shares currently shorted divided by the average quantity of Harpoon Therapeutics shares traded daily (recently around 269059.12698413). Harpoon Therapeutics's SIR currently stands at 2.52. In other words for every 100,000 Harpoon Therapeutics shares traded daily on the market, roughly 2520 shares are currently held short.

However Harpoon Therapeutics's short interest can also be evaluated against the total number of Harpoon Therapeutics shares, or, against the total number of tradable Harpoon Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Harpoon Therapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Harpoon Therapeutics shares in existence, roughly 20 shares are currently held short) or 0.0383% of the tradable shares (for every 100,000 tradable Harpoon Therapeutics shares, roughly 38 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Harpoon Therapeutics.

Find out more about how you can short Harpoon Therapeutics stock.

Harpoon Therapeutics share dividends

We're not expecting Harpoon Therapeutics to pay a dividend over the next 12 months.

Harpoon Therapeutics share price volatility

Over the last 12 months, Harpoon Therapeutics's shares have ranged in value from as little as $10.27 up to $25.235. A popular way to gauge a stock's volatility is its "beta".

HARP.US volatility(beta: 0.81)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Harpoon Therapeutics's is 0.8089. This would suggest that Harpoon Therapeutics's shares are less volatile than average (for this exchange).

Harpoon Therapeutics overview

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead TriTAC product candidate is HPN424 that is in Phase I clinical trial for the treatment of metastatic castration-resistant prostate cancer. It also develops HPN536, which is in Phase I/IIa clinical trial for the treatment of ovarian cancer and other MSLN-expressing tumors; HPN217 for the treatment of multiple myeloma; and HPN328 for the treatment of SCLC. The company has a collaboration agreement with AbbVie Biotechnology Ltd. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site